Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy (OPTI-PP)
Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy in the Hepato-Gastroenterology Department of the Nîmes University Hospital
The main objective of this study is to evaluate the impact of the presence of a pharmacy technician in a care unit (Hepato-Gastroenterology Department) on detected medication errors.
This is a before-after study consisting of three sequential phases:
Month 1: one month of observation of what is happening in the department Month 2: one month wash out period Month 3: active participation of a pharmacy technician in the department
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The secondary objectives of this study are:
A- To assess the impact of the presence of a pharmacy technician on the ratio of the number of patients with at least one medication error / number of included patients hospitalized in the service.
B- To characterize detected medication errors.
C- To identify and evaluate the potential causes of medication errors.
D- To evaluate whether the presence of a pharmacy technician reduces nursing time spent on medication management.
E- To evaluate the economic impact of the presence of a pharmacy technician.
F- To evaluate the acceptability of the intervention by the nursing staff and pharmacy technicians using questionnaires.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Nîmes Cedex 09, Francia, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- The patient must be insured or beneficiary of a health insurance plan
- The patient is hospitalized in the Hepato-Gastroenterology Department of the Nîmes University Hospital
Exclusion Criteria:
- The patient is under judicial protection
- The patient, or his/her legal guardian, expresses opposition to participation in the study
- It is impossible to correctly inform the patient
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: 1st observational period (before experimental intervention)
Patients in this arm are included during a first month of observation before the intervention is implemented. Intervention: One month of department-wide observation |
A pharmacy technician will be present full time in the care unit from Monday to Friday between 8:30 and 17h for 1 month for observational purposes only.
During this phase, the pharmacy technician observes the current practices of preparation and administration of medication by nurses.
He / she will collect medication errors and other observational data.
|
|
Experimental: 2nd obs. period (during experimental intervention)
Following a one-month wash-out period, patients in this arm are included during a second month of observation during which the intervention is implemented. Intervention: Pharm Tech participates in department |
Following a 1 month wash-out period, a pharmacy technician will again be present full time (in practice, two technicians will relay each other) in the care unit from Monday to Friday between 8:30 and 17h for 1 month.
He/she will actively take part in drug care activities in the department: management of product pathways, verification of injectable preparation, advice, etc. Medication errors and other observational data will be collected.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
The following ratio (relative units): Number of medication errors / number of medications administered and omitted from among all those listed on the prescription for admission
Periodo de tiempo: 5 days
|
Primary Outcome Measure as given in protocol: Number of medication errors / number of medications administered and omitted from among all those listed on the prescription for admission (during month 1 versus during month 3).
|
5 days
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of patients with at least one medication error / total number of hospitalized patients included in the service
Periodo de tiempo: 5 days
|
5 days
|
|
|
For each medication error: the name of the drug
Periodo de tiempo: 5 days
|
5 days
|
|
|
For each medication error: the type of error
Periodo de tiempo: 5 days
|
Errors are classifies as one of the following types: Omission; Drug; Dosage form; Expired or damaged drug; Dose; Concentration; Frequency of administration; Administration technique; Route of Administration; Rate of administration; Duration of administration; Administration Time; Patient; Drug interaction. |
5 days
|
|
For each medication error: the severity index
Periodo de tiempo: 5 days
|
5 days
|
|
|
For each medication error: when (which step) the error occurred during the drug pathway
Periodo de tiempo: 5 days
|
The considered steps are: Writing the prescription Medical decision for the prescription Transcription Pharmaceutical analysis Deliverance Preparation / reconstitution Pillbox Administration Procurement Storage Compliance Therapeutic and clinical follow-up |
5 days
|
|
For each medication error: the evolution of the adverse drug event, if occurred
Periodo de tiempo: 5 days
|
5 days
|
|
|
For each medication error: the criticality of the error
Periodo de tiempo: 5 days
|
Criticality is graded according to the following classes:
3E: treatment or surgery with temporary harm 3F: longer duration of hospitalization with temporary harm 3G: permanent harm 3H: involving a life-threatening harm 3I: death Criticality is determined by the concordance of two, independent expert opinions; or, in case of discordance, the concordance of 2 out 3 expert opinions. |
5 days
|
|
The potential causes of medication errors
Periodo de tiempo: 5 days
|
5 days
|
|
|
The average number of interruptions per hour during preparation or administration of drug doses by nurses
Periodo de tiempo: 5 days
|
5 days
|
|
|
The number of patients for whom personal treatments were managed by the nursing staff on admission / number of patients who brought their personal treatments to the care unit
Periodo de tiempo: 5 days
|
5 days
|
|
|
The number of patients for whom personal treatments were returned by the nursing staff at hospital discharge / number of patients who brought their personal treatments to the care unit
Periodo de tiempo: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: the preparation of individual doses
Periodo de tiempo: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: ordering health products
Periodo de tiempo: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: stock management and exceptional orders
Periodo de tiempo: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: the delivery, receipt and storage of health products
Periodo de tiempo: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: cabinet inventories
Periodo de tiempo: 5 days
|
5 days
|
|
|
Nursing staff time dedicated to: the management of expired drugs
Periodo de tiempo: 5 days
|
5 days
|
|
|
The number of calls made to the central pharmacy
Periodo de tiempo: 5 days
|
5 days
|
|
|
Staff time dedicated to managing exceptional requests
Periodo de tiempo: 5 days
|
5 days
|
|
|
The number of drugs consumed
Periodo de tiempo: 5 days
|
5 days
|
|
|
The number of medical devices consumed
Periodo de tiempo: 5 days
|
5 days
|
|
|
The number of immobilized drugs
Periodo de tiempo: 5 days
|
5 days
|
|
|
The number of immobilized medical devices
Periodo de tiempo: 5 days
|
5 days
|
|
|
The cost of adverse drug events care
Periodo de tiempo: 5 days
|
5 days
|
|
|
Care staff satisfaction questionnaire
Periodo de tiempo: 5 days
|
5 days
|
|
|
Pharmacy technician satisfaction questionnaire
Periodo de tiempo: 5 days
|
5 days
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Géraldine Leguelinel-Blache, PharmD, PhD, Centre Hospitalier Universitaire de Nîmes
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- LOCAL/2015/GL-01
- 2015-A01309-40 (Otro identificador: RCB number)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .